0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 asia pacific her2 erbb2 antibodies market report 2018.Your search for "" gave back 1533066 results.
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Patuzumab is a monoclonal antibody. It was the first monoclonal antibody called an "HER dimerization inhibitor." By binding to HER2, it...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 6,231 project entries for...
Catalog:
La Merie Publishing
August 2023
Price: USD 1,760.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „ Antibody-Drug Conjugate Pipeline...
Catalog:
La Merie Publishing
December 2016
Price: USD 880.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about Bispecific Antibodies...
Catalog:
La Merie Publishing
June 2019
Price: USD 900.00
The global Receptor Tyrosine Protein Kinase ERBB 3 market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Highlights The global Receptor Tyrosine Protein Kinase ERBB 4 market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Receptor Tyrosine Protein Kinase ERBB 3 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The 17th edition of the report series about sales of Blockbuster Biologics. This report provides a compilation of the sales data of originator...
Catalog:
La Merie Publishing
March 2023
Price: USD 528.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
